Insider Trading: BioCryst Pharmaceuticals Inc (BCRX.O)

BCRX.O on Nasdaq

1.59USD
24 May 2013
Price Change (% chg)

$-0.07 (-4.22%)
Prev Close
$1.66
Open
$1.63
Day's High
$1.69
Day's Low
$1.58
Volume
845,333
Avg. Vol
1,480,592
52-wk High
$4.95
52-wk Low
$1.08

Search Stocks
STAAB THOMAS R II
Trading Date Type Shares Traded Price Shares Held
28 Feb 2013 Sell 542 $1.19 49,322
30 Jan 2013 Buy 2,745 $1.38 52,609
31 Dec 2012 Buy 8,500 $0.00 49,864
31 Dec 2012 Buy 8,500 $0.00 49,864
30 Jun 2012 Sell 8,113 $3.97 31,617
14 Mar 2012 Buy 11,989 $0.00 37,124
14 Mar 2012 Sell 4,162 $5.23 37,124
29 Feb 2012 Buy 5,600 $0.00 30,600
30 Jun 2011 Buy 25,000 $0.00 25,000
Previous Page 1 of 1

Institutional Holders

% Shares Owned: 32.07%
# of Holders: 81
Total Shares Held: 17,045,000
3 Mo. Net Change: -331,895
# New Positions: 6
# Closed Positions: 15
# Increased Positions: 24
# Reduced Positions: 46
# Net Buyers: -22

Officers & Directors

Name Age Since Current Position

George Abercrombie

 2013 Non-Executive Chairman of the Board

Jon Stonehouse

 51 2007 President, Chief Executive Officer, Director

Thomas Staab

 44 2013 Chief Financial Officer, Senior Vice President, Principal Accounting Officer, Treasurer

William Sheridan

 57 2008 Senior Vice President, Chief Medical Officer

Yarlagadda Babu

 59 2008 Vice President - Drug Discovery

Stanley Erck

 64 2008 Independent Director

Nancy Hutson

 62 2012 Independent Director

Peder Jensen

 57 2011 Independent Director

Kenneth Lee

 64 2011 Independent Director

Charles Sanders

 80 2009 Independent Director

Rob Bennett

 Executive Director - Investor Relations & Communications
Search Stocks